S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer

Angiogenesis in solid tumors is divided into two modes: endothelium-dependent vessel (EDV) and vasculogenic mimicry (VM). Sphingosine-1-phosphate receptor 1 (S1PR1) plays a vital role on EDV in a variety of human tumors. However, the relationship between S1PR1 and VM is not clear. The aim of this st...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease 2019-02, Vol.10 (3), p.200-200, Article 200
Main Authors: Liu, Shuang, Ni, Chunsheng, Zhang, Danfang, Sun, Huizhi, Dong, Xueyi, Che, Na, Liang, Xiaohui, Chen, Chen, Liu, Fang, Bai, Jingru, Lin, Xian, Zhao, Xiulan, Sun, Baocun
Format: Article
Language:English
Subjects:
13/1
13/51
14/28
42/109
631/67/1347
631/80/86
64/60
Angiogenesis
Antibodies
Biochemistry
Biomedical and Life Sciences
Breast cancer
Cadherins
Cell Biology
Cell Culture
Endothelium
Immunology
Life Sciences
Metastases
Mimicry
Phosphorylation
RhoA protein
Solid tumors
Sphingosine 1-phosphate
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Angiogenesis in solid tumors is divided into two modes: endothelium-dependent vessel (EDV) and vasculogenic mimicry (VM). Sphingosine-1-phosphate receptor 1 (S1PR1) plays a vital role on EDV in a variety of human tumors. However, the relationship between S1PR1 and VM is not clear. The aim of this study is to investigate S1PR1 on the regulation of EDV and mimicry formation in breast cancer. Here we show that S1PR1 phosphorylates the complex of VE-cadherin to regulate the switch of EDV and mimicry formation. Suppression of S1PR1 impairs EDV, but contributes to the generation of VM, invasion, and metastasis in vivo and vitro. By inhibiting RhoA activation, the S1PR1/VE-cadherin signaling is blocked. S1PR1 controls VE-cadherin expression and EDV via RhoA activation. Moreover, the low expression of S1PR1 correlates with VM and poor prognosis in breast cancer patient. The results show that S1PR1 regulated RhoA activation to accelerate VE-cadherin phosphorylation (Y731), leading to increased EDV and reduced VM in breast cancer. S1PR1 may provide a new thinking direction for antiangiogenic therapy for patients with breast cancer.
ISSN:2041-4889
2041-4889
DOI:10.1038/s41419-019-1411-x